Last reviewed · How we verify

without triamcinolone

Peking University Third Hospital · FDA-approved active Small molecule

This drug is a corticosteroid that suppresses inflammation and immune responses.

This drug is a corticosteroid that suppresses inflammation and immune responses. Used for Asthma, Allergic rhinitis, Atopic dermatitis.

At a glance

Generic namewithout triamcinolone
Also known asPlacebo
SponsorPeking University Third Hospital
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaOncology, Dermatology, Rheumatology
PhaseFDA-approved

Mechanism of action

Triamcinolone is a synthetic glucocorticoid that has potent anti-inflammatory and immunosuppressive properties. It works by binding to glucocorticoid receptors in cells, which then translocate to the nucleus and regulate the expression of genes involved in inflammation and immune responses.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results